• Bhargava, M., Joseph, A., Knesel, J., Halaban, R., Li, Y., Pang, S., Goldberg, I., Setter, E., Donovan, M. A. and Zarnegar, R., Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differentiation, 3, 1120 (1992).
  • Bigner, S. H., Burger, P. C., Wong, A. J., Werner, M. H., Hamilton, S. R., Muhlbaier, L. H., Vogelstein, B. and Bigner, D. D., Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J. Neuropathol. exp. Neurol., 47, 191205 (1988).
  • Di Renzo, M. F., Narshimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Medico, E., Gaglia, P., Zara, P. and Comoglio, P. M., Expression of the Met/HGF receptor in normal and neoplastic tissues. Oncogene, 6, 19972003 (1991).
  • Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P. and Rosen, E. M., Scatter factor induces blood vessel formation in vivo. Proc. nat. Acad. Sci. (Wash.), 90, 19371941 (1993).
  • Mark, M. R., Lokker, N. A., Zioncheck, T. F., Luis, E. A. and Godowski, P. J., Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins: effects of mutations in the potential proteolytic cleavage sites on processing and ligand binding. J. biol. Chem., 267, 2616626171 (1992).
  • Millauer, B., Shawver, L. K., Plate, K. H., Risau, W. and Ullrich, A., Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature (Lond.), 367, 576579 (1994).
  • Moriyama, T., Kataoka, H., Tsubouchi, H. and Koono, M., Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett., 372, 7882 (1995).
  • Noji, S., Tashiro, K., Koyama, E., Nohno, T., Ohyama, K., Taniguchi, S. and Nakamura, T., Expression of hepatocyte growth factor gene in endothelial and Kupffer's cells of damaged rat livers as revealed by in situ hybridization. Biochem. biophys. Res. Commun., 173, 4247 (1990).
  • Plate, K. H., Breier, G., Millauer, B., Ullrich, A. and Risau, W., Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res., 53, 58225827 (1993).
  • Prat, M., Narsimhan, R. P., Crepaldi, T., Nicotra, M. R., Natali, P. G. and Comoglio, P. M., The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer, 49, 323328 (1991).
  • Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R. and Rubin, R., Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res., 54, 22182222 (1994).
  • Rosen, E. M., Joseph, A., Jin, L., Rockwell, S., Elias, J. A., Knesel, J., Wines, J., McClellan, J., Kluger, M. J., Goldberg, I. D. and Zitnik, R., Regulation of scatter factor production via a soluble inducing factor. J. Cell Biol., 127, 225234 (1994a).
  • Rosen, E. M., Knesel, J., Goldberg, I. D., Jin, L., Bhargava, M., Joseph, A., Zitnik, R., Wines, J., Kelley, M. and Rockwell, S., Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J. Cancer, 57, 706714 (1994b).
  • Rosen, E. M., Nigam, S. K. and Goldberg, I. D., Scatter factor and the c-met receptor: a paradigm for mesenchymal epithelial interaction. J. Cell Biol., 127, 17831787 (1994c)
  • Schrock, E., Thiel, G., Lozanova, T., Du Manoir, S., Meffert, M. C., Jauch, A., Speicher, M. R., Nurnberg, P., Vogel, S. and Janisch, W., Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Amer. J. Pathol., 144, 12031218 (1994).
  • Seki, T., Hagiya, M., Shimonishi, M., Nakamura, T. and Shimizu, S., Organization of the human hepatocyte growth factor-encoding gene. Gene, 102, 213219 (1991).
  • Seslar, S. P., Nakamura, T. and Byers, S. W., Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res., 53, 12331238 (1993).
  • Stoker, M., Gherardi, E., Perryman, M. and Gray, J., Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (Lond.), 327, 238242 (1987).
  • Tamura, M., Arakaki, N., Tsoubouchi, H., Takada, H. and Daikuhara, Y., Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J. biol. Chem., 268, 81408145 (1993).
  • Vassbotn, F. S., Ostman, A., Langeland, N., Holmsen, H., Westermark, B., Heldin, C. H. and Nister, M., Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J. Cell Physiol., 158, 381389 (1994).
  • Weidner, K. M., Hartmann, G., Sachs, M. and Birchmeier, W., Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Amer. J. Respir. Cell mol. Biol., 8, 229237 (1993).
  • Wullich, B., Sattler, H. P., Fischer, U. and Meese, E., Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene met. Anticancer Res., 14, 577579 (1994).
  • Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T. and Shin, S., Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54, 16301633 (1994).
  • Yanagita, K., Nagaike, M., Ishibasi, H., Niho, Y., Matsumoto, K. and Nakamura, T., Lung may have endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. biophys. Res. Commun., 182, 802809 (1992).